摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-oxo-6-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)-1,4-dihydroquinoline-3-carboxylic acid | 388621-83-8

中文名称
——
中文别名
——
英文名称
4-oxo-6-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)-1,4-dihydroquinoline-3-carboxylic acid
英文别名
4-oxo-6-[[3-(trifluoromethyl)phenyl]sulfamoyl]-1H-quinoline-3-carboxylic acid
4-oxo-6-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)-1,4-dihydroquinoline-3-carboxylic acid化学式
CAS
388621-83-8
化学式
C17H11F3N2O5S
mdl
——
分子量
412.346
InChiKey
VHQXJFGBSBYNKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    121
  • 氢给体数:
    3
  • 氢受体数:
    10

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-oxo-6-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)-1,4-dihydroquinoline-3-carboxylic acid环己胺 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 12.25h, 以35.6%的产率得到N-cyclohexyl-4-oxo-6-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)-1,4-dihydroquinoline-3-carboxamide
    参考文献:
    名称:
    4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: Synthesis, biological evaluation and docking studies
    摘要:
    In this work, we report a series of new 4-oxo-1,4-dihydro-quinoline-3-carboxamide derivatives as,beta-secretase (BACE-1) inhibitors. Supported by docking study, a small library of derivatives were designed, synthesized and biologically evaluated in vitro. The studies revealed that the most potent analog 14e (IC50 = 1.89 mu M) with low cellular cytotoxicity and high predicted blood brain barrier permeability, could serve as a good structure for further modification.(c) 2014 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2014.04.025
  • 作为产物:
    参考文献:
    名称:
    4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: Synthesis, biological evaluation and docking studies
    摘要:
    In this work, we report a series of new 4-oxo-1,4-dihydro-quinoline-3-carboxamide derivatives as,beta-secretase (BACE-1) inhibitors. Supported by docking study, a small library of derivatives were designed, synthesized and biologically evaluated in vitro. The studies revealed that the most potent analog 14e (IC50 = 1.89 mu M) with low cellular cytotoxicity and high predicted blood brain barrier permeability, could serve as a good structure for further modification.(c) 2014 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2014.04.025
点击查看最新优质反应信息

文献信息

  • COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS
    申请人:VM Discovery, Inc.
    公开号:EP2194783A1
    公开(公告)日:2010-06-16
  • [EN] COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING BCL-2 FAMILY MEMBER PROTEINS<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE MODULATION DE L'APOPTOSE DANS DES CELLULES SUREXPRIMANT DES PROTÉINES MEMBRES DE LA FAMILLE BCL-2
    申请人:HUTCHINSON FRED CANCER RES
    公开号:WO2008021250A2
    公开(公告)日:2008-02-21
    [EN] The present invention relates to compounds for modulating apoptosis in cells over expressing Bcl-2 Family member proteins. The present invention also relates to pharmaceutical compositions containing these compounds, and methods of using the compounds.
    [FR] La présente invention concerne des composés permettant de moduler l'apoptose dans des cellules surexprimant des protéines membres de la famille Bcl-2. La présente invention concerne également des compositions pharmaceutiques contenant ces composés, et des procédés d'utilisation desdits composés.
  • [EN] COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR MODULATEURS D'APOPTOSE
    申请人:VM DISCOVERY INC
    公开号:WO2009023558A1
    公开(公告)日:2009-02-19
    The present invention includes relates generally to compounds which modulate apoptosis in cells. The present invention also provides pharmaceutical compositions containing these compounds, methods of making these compounds, and methods of using these compounds and pharmaceutical compositions for treatment of diseases associated with irregular apoptosis in cells.
查看更多